🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, open-label , multicenter randomized controlled trial...
Status
Unknown
Location
Multiple Locations
Start Date
2019-10-15
Trial ID
NCT04131231
Treatments Being Tested
Multidrug-resistant tuberculosis (MDR-TB) has emerged as a challenge worldw...
Status
Unknown
Location
the First Affiliated Hospital of Nanjing Medical University
Start Date
2009-06-01
Trial ID
NCT03069534
Treatments Being Tested
This study will find the highest acceptable treatment dose of cord blood, c...
Status
Terminated
Location
Beth Israel Deaconess Medical Center
Start Date
2016-07-11
Trial ID
NCT02781467
Treatments Being Tested
A Phase 1/2a Open Label Multicenter, Non-Randomized, Trial to Assess the Sa...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-09
Trial ID
NCT05218408
Treatments Being Tested
This study is a randomized, controlled, single-center clinical study to eva...
Status
Unknown
Location
The Second Xiangya Hospital of Central South University
Start Date
2021-06-16
Trial ID
NCT04893980
Treatments Being Tested
After complete remission, elderly AML patients cannot tolerate hematopoieti...
Status
Unknown
Location
The first affiliated hospital of Xi'an jiaotong university
Start Date
2021-02-01
Trial ID
NCT04687657
Treatments Being Tested
This study will find the maximum tolerated dose (MTD) of CYNK-101 which con...
Status
Terminated
Location
Scripps Health
Start Date
2022-04-14
Trial ID
NCT05207722
The study aims to explore the therapeutic value and mechanism of Interleuki...
Status
Completed
Location
Sirui Yang
Start Date
2020-06-14
Trial ID
NCT04387942
Treatments Being Tested
This study will find the highest acceptable treatment dose and timing of in...
Status
Completed
Location
University of Minnesota
Start Date
2017-01-05
Trial ID
NCT02955550
The investigators evaluate the effectiveness and safeness of low-dose Recom...
Status
Unknown
Location
Department of Rheumatology and Immunology, Peking University People's Hospital
Start Date
2014-06
Trial ID
NCT02569463
Treatments Being Tested